Andrew M. Lowy, MD
Andrew M. Lowy, MD is Professor of Surgery, Chief of the Division of Surgical Oncology and Clinical Director for Cancer Surgery at Moores Cancer Center and UC San Diego Health. Dr Lowy is a physician-scientist who is recognized worldwide for his expertise in the surgical treatment of pancreatic cancer and for investigating novel cancer treatments which incorporate surgery and chemotherapy to treat patients with advanced cancer that has spread to the abdomen. Dr. Lowy is chair of the National Cancer Institute’s Pancreatic Cancer Task Force which is charged with setting the direction of clinical research in pancreatic cancer in the United States. He also serves as surgical liaison to the Pancreas sub-committee of SWOG, which is one of the largest National Cancer Institute cooperative groups. Dr. Lowy's laboratory focuses on the study of pancreatic cancer signaling and preclinical modeling and he collaborated to develop the first genetically engineered mouse model of pancreatic cancer currently used in laboratories worldwide. His lab has been continuously funded by the National Institutes of Health/National Cancer Institute to study pancreatic cancer since 1999.